Rugiet Health Revenue and Competitors

Austin, TX USA

Location

N/A

Total Funding

Fitness

Industry

Employee Data

  • Rugiet Health has 51 Employees.(i)
  • Rugiet Health grew their employee count by 28% last year.

Rugiet Health's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M1503%N/AN/A
#2
N/A96-7%N/AN/A
#3
N/A9840%N/AN/A
#4
N/A11-27%N/AN/A
#5
$15M12919%N/AN/A
#6
N/A30%N/AN/A
#7
N/A1525%N/AN/A
#8
$7.5M1029%N/AN/A
#9
N/A3338%N/AN/A
#10
N/A9121%N/AN/A
Add Company

What Is Rugiet Health?

We provide access to compound medications online, but we’re a people company, first. \n\nRugiet Health doesn’t believe in carpet-bombing personal health issues with generic medication. Treating medical conditions should be an intimate and empowering experience. We want our customers to feel like more than a random number and a barcode on the side of an orange pill bottle. Every Rugiet Health treatment is made on a per-patient basis with the most advanced compound medications. \n\nIn 2020, after 5 years of R&D, we launched our first erectile dysfunction treatment. We believe in giving our patients the power of choice, but not when it's one or the other. So, we combined the active ingredients in Viagra and Cialis for the best of both worlds. Then, we took that potent formulation and put it in sublingual form. Rugiet Ready is a minty-fresh troche that melts under your tongue and starts to work 5X faster.\n\nAnd we're just getting started. We continue to improve medical solutions for men and women across a multitude of disease states. We're focused on those conditions that do not receive as much attention from commercial solutions. We will continue to innovate drug-therapy so that every person can live full, happy, pain-free lives.

keywords:N/A

N/A

Total Funding

51

Number of Employees

N/A

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.1M51-9%N/A
#2
$7.9M51-6%N/A
#3
$11.5M514%N/A
#4
$6.7M51N/AN/A
#5
$7.3M51N/AN/A